Michael Avery and a panel of experts talk about the US backing India and SA’s bid to temporarily lift patent protection for Covid-19 vaccines
Ascendis Health CEO Mark Sardi talks to Business Day TV about swapping its European assets for debt
The debt-laden group’s shares rose more than 14% after it said it had struck a deal with lenders to swap many of its best assets for debt
The group’s shares are on track for their worst day in two months after rocketing 42% ahead of a deadline for restructuring talks
Vaccine producer hikes sales forecast, up from nearly €10bn, as orders roll in
Mudiwa Gavaza is joined by Ryan Noach, the CEO of Discovery Health
Gap cover is one area that shows the need for more education
Mudiwa Gavaza speaks to Dr Ernest Darkoh, a founding partner of the BroadReach Group
Private hospital operator says Covid-19 weighed on first-half core profit
Business for SA head Stavros Nicolaou talks to Business Day TV about getting South Africans vaccinated
The private hospital operator had expected to return to prepandemic performance in 2022
MG Health has been positioned as the first manufacturer in Africa able to export medicinal cannabis to the EU
Vaccitech owns the technology behind the Covid-19 vaccine developed by Oxford and AstraZeneca
The vaccine uses the whole, inactivated virus to create an immune response, an old but proven approach
Hospital group and government trade allegations
The group is battling with R6.6bn net debt burden, and an expensive debt structure, prompting recapitalization talks with lenders
Wits University’s health & social security systems specialist, Alex van den Heever, talks to Business Day TV
DNA sequencing group could be valued at £4bn in UK float
German biotech company’s chief says the company is developing a vaccine that can be stored in a fridge and a freeze-dried version useful for stockpiling
CEO Adrian Gore says SA on the brink of securing vaccines to cover more than 37-million adults
